D.E. Shaw & Co
REVH

D.E. Shaw & Co’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

D.E. Shaw & Co’s Portfolio REVH Stock Details REVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-390,687
Closed -$3.84M – 5473
2022
Q3 		$3.84M Hold
390,687
– – ﹤0.01% 2376
2022
Q2 		$3.81M Hold
390,687
– – ﹤0.01% 2463
2022
Q1 		$3.83M Sell
390,687
-443,023
-53% -$4.31M ﹤0.01% 2627
2021
Q4 		$8.1M Buy
833,710
+694,079
+497% +$6.78M 0.01% 1878
2021
Q3 		$1.36M Buy
139,631
+84,324
+152% +$821K ﹤0.01% 3363
2021
Q2 		$543K Buy
+55,307
New +$545K ﹤0.01% 4000

D.E. Shaw & Co's REVH Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 390,687 shares — an estimated $3.84M sold.

D.E. Shaw & Co first reported a position in REVH in Q2 2021 and held it in 6 quarters. The position peaked at $8.1M in Q4 2021. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 390,687 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $3.84M.
  • D.E. Shaw & Co first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • D.E. Shaw & Co's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $8.1M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.